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Interleukin-1 and interleukin-6 are principal cytokines involved in regulation of expression of acute-phase proteins. In the joint action of both
cytokines IL-1 can suppress or enhance the IL-6-dependent induction of gene expression. Here, we report changes in the transcriptome profile of
HepG2 cells exposed to IL-6 alone, or IL-1 and IL-6. Cytokine-responsive genes were identified by differential display analysis. Validation of
observed changes in the transcript level was carried out using the slot blot method. Out of 88 cDNA species modulated by IL-6, only 38 represent
different known genes whereas 18 clones match genomic clones in NCBI data with hypothetical cDNA sequences (the remaining 32 clones
showed no homology with the database or represented several clones of the same gene). In the experiments with HepG2 cells prestimulated for 3
h with IL-1 and then stimulated with IL-6, 43 cDNA fragments were amplified. Twenty-three of them represent known genes while 10 clones have
inserts matching hypothetical cDNA sequences in NCBI data. The identified transcripts modulated by IL-6 or both cytokines in HepG2 cells code
for intracellular proteins of various function. The largest groups represent genes engaged in metabolism, protein synthesis and signaling pathways.
Among all genes identified as differentially regulated under stimulation by IL-6, or IL-1/IL-6, six were detected in both types of stimulation. None
of the typical genes coding for plasma acute phase proteins was identified in our experiments. This indicates that differential display cannot be
used to characterize the profile of a given transcriptome. On the other hand, it is a useful technique for detection of new genes responding to IL-6
alone or IL-6 in combination with IL-1.
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The acute phase reaction has been defined as a character-
istic response of the animal organism to various forms of
injuries (for description of molecular mechanism and earlier
references see [1–3]). The systemic acute phase reaction is
initiated by proinflammatory cytokines such as interleukin-1
and tumor necrosis factor, as well as by acute phase cytokines
from the interleukin-6 family. These cytokines are released
from activated macrophages, fibroblasts, keratinocytes or0925-4439/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2005.11.001
Abbreviations: IL-1h, interleukin-1 beta; IL-6, interleukin-6; DD-PCR,
differential display-polymerase chain reaction; AGP, a1-acid glycoprotein;
HPT, haptoglobin; MnSOD, manganese-dependent superoxide dismutase
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E-mail address: koj@mol.uj.edu.pl (A. Koj).endothelial cells and stimulate liver and other tissues to
synthesis of acute phase proteins. The cytokine-modulated
expression of genes coding for liver-derived plasma proteins is
either upregulated (positive acute phase proteins) or down-
regulated (negative acute phase reactants) [1]. Moreover, the
action of IL-1 and IL-6 can be synergistic or antagonistic:
synthesis of a1-acid glycoprotein or serum amyloid A induced
by IL-1 is further enhanced by IL-6, whereas expression of
fibrinogen is IL-6 dependent and IL-1 behaves as a negative
regulator [1,4]. Although abundant information is available on
the expression of genes coding for individual plasma and
cellular proteins modulated by various cytokines very few
attempts have been made so far to compare the profile of the
whole transcriptome analysed by currently available techni-
ques such as subtractive hybridization, differential display or
microarrays (for review, see [3]).1762 (2006) 319 – 328
http://www
P. We˛grzyn et al. / Biochimica et Biophysica Acta 1762 (2006) 319–328320By using cultured human hepatoma cells (HepG2 cells)
and differential display analysis, we have already shown that
the cellular response to IL-1 is highly complex and
encompasses activation of genes encoding intracellular
proteins of various function: trafficking/motor proteins,
proteins participating in the translation machinery or post-
transcriptional/posttranslational modifications, proteases, pro-
teins involved in metabolism, activity modulators and proteins
of the cell cycle machinery [5]. In order to expand these
studies, we evaluated changes in gene expression of HepG2
cells stimulated by IL-6, or by the joint action of IL-1 and IL-
6. According to our experimental protocol cells were
pretreated with IL-1 for 3 h and then stimulated with IL-6.
This was based on the observation of Uhlar and Whitehead
[6] who showed that stimulation with IL-1 prior to IL-6 was
essential for maximal synergistic transcriptional induction of
human serum amyloid A promoter inserted upstream of a
luciferase reporter gene. Similar results were obtained by
Thorn et al. [7] in hepatic and epithelial cell lines stimulated
with TNFa and IL-6. Such order of cytokine delivery is also
close to the sequence of events in vivo [8]. On the other
hand, several authors [9,10] reported that pretreatment of
HepG2 cells with IL-1 inhibits formation of the IL-6-induced
STAT complexes that are involved in the expression of many
acute phase protein genes [11].
In the experiments described here carried out with the
employment of differential display analysis, we found that the
number of transcripts modulated by IL-6 alone is much higher
than after pretreatment of cells with IL-1 before stimulation
with IL-6. This indicates that inhibitory effects of IL-1 on the
acute phase response prevail over possible synergistic action of
the two tested cytokines. Although we identified several newFig. 1. Time and dose dependent changes in the level of transcripts encoding acu
haptoglobin (HPT) and a1-acid glycoprotein (AGP) in HepG2 cells stimulated with
both cytokines cells were treated with 10, 15, 30 ng/ml of IL-1; 15, 25, 50 ng/ml of I
MnSOD only the smaller transcript is presented. For other details see Results.genes not known to be controlled by IL-1 and/or IL-6, we did
not detect mRNAs coding for acute phase plasma proteins.
This may be due to accidental annealing of the used primers
with the most abundant mRNA species while certain transcripts
remain undetected. However, such an outcome represents a
serious limitation of the differential display technique.
2. Materials and methods
2.1. Cell culture and cytokine treatment
HepG2 cells (from ATCC, passages 11–16) were grown to 70% confluence
in plastic Petri dishes (10 cm in diameter, TPP, Switzerland), at 37 -C and 5%
CO2 in Dulbecco Modified Eagle Medium (DMEM) with 1000 mg/L d-
glucose (Gibco/BRL) supplemented with 10% foetal bovine serum (FBS). At
24 h before the experiment cells were placed in DMEM containing 0.5% FBS.
Finally, HepG2 cells were stimulated with IL-6, or prestimulated for 3 h with
IL-1 and then stimulated with IL-6, for the time indicated. Human IL-1h was a
gift from Dr. C. Dinarello (Denver, CO, U.S.A.) and human recombinant IL-6
was purchased from ICN (USA). The responsiveness of HepG2 cells to these
cytokines was evaluated in each series of experiments by comparing changes in
the levels of mRNA coding for known acute phase proteins (Fig. 1). Changes
in the level of appropriate mRNAs were determined by Northern blot as
recently described by us [5]. In the experiments with differential display
analysis, final concentrations of IL-1h in the tissue culture media were 15 ng/
ml, and IL-6–25 ng/ml.
2.2. Differential display analysis
Expression studies were carried out with the use of total RNA isolated
from unstimulated (control) and IL-6-stimulated cells, or from control and cells
prestimulated by IL-1h (3 h) and then stimulated with IL-6 for different time
periods. Differential display analysis was carried out with cDNA synthesized
on the whole RNA template, with oligo(dT) primers. Each PCR reaction, done
with 10 oligo(dT) and 9 arbitrary primers (Clontech, USA) (shown in Table 1),
consisted of two stages: in stage one, three cycles were performed at lowte phase proteins: mitochondrial manganese superoxide dismutase (MnSOD),
IL-1, IL-6 or mixture of IL-1/IL-6. To establish the optimal times and doses for
L-6 during 4, 12 and 24 h. Unstimulated cells served as a control (C). In case of
Table 1
The sequence of primers designed by Clontech and used in DD-PCR
Arbitrary primers Oligo(dT) primers
P1: 5V-ATTAACCCTCACTAAATGCTGGGGA T1: 5V-CATTATGCTGAGTGATATCTTTTTTTTTAA
P2: 5V-ATTAACCCTCACTAAATCGGTCATAG T2: 5V-CATTATGCTGAGTGATATCTTTTTTTTTAC
P3: 5V-ATTAACCCTCACTAAATGCTGGTGG T3: 5V-CATTATGCTGAGTGATATCTTTTTTTTTAG
P4: 5V-ATTAACCCTCACTAAATGCTGGTAG T4: 5V-CATTATGCTGAGTGATATCTTTTTTTTTCA
P5: 5V-ATTAACCCTCACTAAAGATCTGACTG T5: 5V-CATTATGCTGAGTGATATCTTTTTTTTTCC
P6: 5V-ATTAACCCTCACTAAATGCTGGGTG T6: 5V-CATTATGCTGAGTGATATCTTTTTTTTTCG
P7: 5V-ATTAACCCTCACTAAATGCTGTATG T7: 5V-CATTATGCTGAGTGATATCTTTTTTTTTGA
P8: 5V-ATTAACCCTCACTAAATGGAGCTGG T8: 5V-CATTATGCTGAGTGATATCTTTTTTTTTGC
P9: 5V-ATTAACCCTCACTAAATGTGGCAGG T9: 5V-CATTATGCTGAGTGATATCTTTTTTTTTGG
P10: 5V-ATTAACCCTCACTAAAGCACCGTCC
P. We˛grzyn et al. / Biochimica et Biophysica Acta 1762 (2006) 319–328 321primer binding temperature (40 -C), which enables non-specific binding of an
arbitrary primer to different cDNA templates. In the second stage, 25 cycles
were performed at higher primer binding temperature, which led to the
decrease of background resulting from amplification of non-specific products,
and the repeatability of obtained results. We developed a method for
fractionating PCR products in polyacrylamide gels of 1.5200200 mm,
having two different acrylamide concentrations: 8% in the lower, and 6% in
the upper part of the gel. The use of two different concentrations enabled us to
retain in the lower part of the gel products of 200–600 bp, while 6%
acrylamide of the upper part of the gel enabled correct separation of fragments
ranging from 600 to 2200 bp. The silver staining method was used to visualize
individual bands (Fig. 2). Differentiating bands were excised with a scalpel
from the gel immediately after the end of electrophoresis, or after the gel had
been dried. The excised gel fragments were incubated in sterile water for 1 h in
order to release cDNA used subsequently for reamplification. The products
were separated on agarose gel, purified with a PCR product purification kit
(Qiagen, USA) and cloned into type T/A pTZ57R vector (Fermentas,
Lithuania). The obtained colonies (3 colonies from each plate) were subjected
to alkaline lysis, and then sequenced.
2.3. Sequencing
Clones with a ligated insert were sequenced in one direction using the
reverse primer M13 lacZ in a Perkin Elmer 9700 Thermal Cycler at 96 -C for
10 s, 50 -C for 5 s, 60 -C for 2 min for 25 cycles. Cycle sequencing reaction
was performed in 20 Al of total reaction mixture consisting of: 4 Al ABI PrismFig. 2. Representative picture of differential display analysis. PCR products
were separated on native polyacrylamide gel and visualized by silver staining.
Differentially expressed transcript encoding EID-1-like inhibitor of differenti-
ation-2 (EID2) was marked on a gel. Confirmation of modulated expression of
EID2 under IL-6 stimulation presents Fig. 3A.BigDay Terminator v. 1.1 Cycle Sequencing Ready Reaction Kit (Applied
Biosystems, UK), 2 Al 5 Sequencing Buffer (Applied Biosystems, UK),
3.2 pmol of sequencing primer and approximately 100–200 ng of DNA.
Sequencing reaction products were precipitated with the mixture of 50
Al absolute ethanol and 2 Al 3 M sodium acetate pH 4.6 followed by washing
in 70% ethanol. Electrophoretic separation of sequencing products was carried
out using an ABD3100 DNA Sequencer with 50 cm capillaries. Data analysis
was performed with ABI Prism Sequencing Analysis Software v.2.1. Sequences
of differentially expressed genes were determined by searching the GenBank
data at the National Center for Biotechnology Information using BLAST
program.
2.4. Slot blot
Cytokine-dependent modulated expression of all known genes identified in
differential display analysis was confirmed by the use of slot blot method. The
slot blot apparatus (Schleicher and Schuell, Germany) was assembled
according to the manufacturer. A positively charged nylon filter (Hybond
NX; Amersham Biosciences, UK) was wetted in 10 SSC. Gene fragments
corresponding to identified cDNAs, encoding known transcripts, were
amplified with the use as a template pTZ57R constructs containing respective
cDNA fragments and primers complementary to the vector’s sequence. PCR
products were purified (Qiagen, USA), denatured in 95 -C, 4 min, cooled on ice
and loaded into the slots. Each slot was loaded with 200 ng of the PCR product
corresponding to an individual gene. In the experiment with IL-6 38 probes on
one nylon filter represented cDNA of known genes. In the experiment with
IL-1/IL-6, 23 different probes were loaded. In both experiments genomic DNA
(50 ng) served as control.
Validation of observed changes in gene expression was performed for 3
independent experiments: unstimulated cells (control) and cells stimulated for
different time periods: 4, 12, 24 h. Thus, all together 12 membranes were used
for one experiment with IL-6 stimulation and additional 12 membranes in the
study of IL-1/IL-6 action.
Prehybridization and hybridization were carried out at 65 -C in 1% SDS, 1
M NaCl, 10% dextran sulfate solution. As a molecular probe, the whole cDNA
reaction mixture was used. The reaction was carried out from 5 Ag of total RNA
in 20 Al using SuperScript RNaseH reverse transcriptase (Promega, USA), in
the presence of [a-32P]dCTP. All slot blot signals were verified by measuring
the background of the signal obtained from the control sample (50 ng of
genomic DNA). After washing procedure slot blots were exposed to a
phosphoimager screen and then red out using Molecular Imager FX and
software Quantity One (Biorad, USA).
2.5. Calculation of changes in the level of expression
Slot blot densitometric readings were calculated using Microsoft Excel. The
value of intensity of each analysed band corresponding to individual gene and
appropriate time of stimulation was divided by the value of intensity of
genomic DNA and the final results were calculated as fold change in respect to
the control (see Fig. 3, Tables 2 and 3). The reported values represent the mean
of three independent experiments; statistical analysis was carried out with the
use of t-test.
Fig. 3. A representative picture of slot blot analysis showing changes in the expression of some of the identified genes after stimulation of HepG2 cells with IL-6
(A, B) or the mixture of IL-1/IL-6 (C, D). Fold change corresponds to the ratio of intensity of each analysed band and intensity of genomic DNA band divided by
the corresponding value of 1 h control. For each experiment two controls are shown: unstimulated cells collected after 1 h and 24 h incubation. (A) Individual
bands show the transcript level of genes coding for EID-1-like inhibitor of differentiation-2 (EID2), GAPDH, and NADPH dehydrogenase subunit 2. (B) Results of
densitometric analysis of relative changes in mRNAs abundance as determined by slot blot (meanTSE of 3 independent experiments). Statistical analysis was
carried out with the use of t-test. Lane 1—control, unstimulated HepG2 cells harvested after 1 h of incubation; lane 2—HepG2 cells stimulated with IL-6 for 4 h;
lane 3—HepG2 cells stimulated with IL-6 for 12 h; lane 4—HepG2 cells stimulated with IL-6 for 24 h; lane 5—control, unstimulated HepG2 cells harvested after
24 h of incubation. (C) Individual bands show the transcript level of genes coding for mitochondrial tRNA-Tyr and TNFR-related death receptor 6 after 3
h prestimulation with IL-1 followed by stimulation with IL-6 for different time periods (4, 12, 24 h). (D) Results of densitometric analysis of relative changes in
mRNAs abundance as determined by slot blot (meanTSE of 3 independent experiments). Statistical analysis was carried out with the use of t-test. Lane 1—control,
unstimulated HepG2 cells harvested after 1 h of incubation; lane 2—HepG2 cells stimulated with IL-1 for 7 h and IL-6 for 4 h; lane 3—HepG2 cells stimulated
with IL-1 for 15 h and IL-6 for 12 h; lane 4—HepG2 cells stimulated with IL-1 for 27 h and IL-6 for 24 h; lane 5—control, unstimulated HepG2 cells harvested
after 24 h of incubation.
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Table 2
Classes of 38 genes responding to stimulation of HepG2 cells by IL-6 for the time indicated
Clones GenBank
Accession No.
Genes Fold change Classification
C 1 h 4 h 12 h 24 h C 24 h
8 AY495240.1 NADH dehydrogenase subunit 1 1 2.22T0.45 3.39T0.19* 3.70T0.32r 2.44T0.340 Metabolism
1 AY495242.1 NADH dehydrogenase subunit 2 1 1.19T0.060 1.25T0.060 0.87T0.11 0.81T0.11 Metabolism
1 AY495242.1 NADH dehydrogenase subunit 3 1 1.61T 0.160 1.78T0.16r 2.62T0.10* 1.13T0.07 Metabolism
2 AY495242.1 NADH dehydrogenase subunit 4 1 1.47T0.20 2.30T0.280 1.98T0.06* 1.36T0.22 Metabolism
2 AF275320 Glyceraldehyde-3-phosphate
dehydrogenase
1 0.71T0.080 0.82T0.07 0.93T0.06 1.01T0.04 Metabolism
1 NM_001643.1 Apolipoprotein A-II (APOA2) 1 0.44T0.05* 0.66T0.03* 0.69T0.12 0.78T0.14 Metabolism
1 NM_002225.2 Isovaleryl Coenzyme A dehydrogenase 1 0.47T0.07r 0.77T0.10 0.79T0.08 1.11T0.12 Metabolism
3 BC000629.2 Aspartyl-tRNA synthetase 1 0.63T0.090 1.00T0.15 1.23T0.080 0.91T0.09 Protein synthesis
1 AY495242.1 tRNA-Tyr 1 1.23T0.02* 0.49T0.01* 0.60T0.140 0.74T0.16 Protein synthesis
1 BC067738.1 Eukaryotic translation elongation
factor 1 gamma
1 0.72T0.12 1.10T0.08 1.51T0.130 1.07T0.03 Protein synthesis
2 NM_002212.2 Integrin beta 4 binding protein (ITGB4BP) 1 0.74T0.10r 0.72T0.11r 0.86T0.08 1.08T0.04 Protein synthesis
1 NM_001013.2 Ribosomal protein S9 1 0.47T0.09r 0.47T0.120 0.34T0.06* 0.55T0.100 Protein synthesis
3 BC006781.1 Myosin, light polypeptide 6 1 0.88T0.05 0.83T0.070 0.83T0.09 0.82T0.07 Trafficking
1 X65873.1 Kinesin (heavy chain) 1 0.59T0.08r 1.33T0.100 0.51T0.04* 0.84T0.10 Trafficking
2 NM_001153.2 Annexin A4 (ANXA4) 1 0.48T0.120 0.71T0.19 1.77T0.270 0.80T0.23 Trafficking
1 NM_002778.1 Prosaposin 1 0.88T0.05 1.42T0.26 1.46T0.07r 0.82T0.11 Signaling
intermediates
1 AF029838 Alpha 7 neuronal nicotinic receptor 1 0.80T0.02* 1.19T0.060 0.79T0.09 0.88T0.030 Signaling
intermediates
1 BC005852.1 SPRY domain-containing SOCS box
protein SSB-1
1 0.57T0.02* 1.28T0.090 1.47T0.06r 0.67T0.120 Signaling
intermediates
1 BC058925.1 Intersectin 1 (SH3 domain protein), 1 0.68T0.05r 1.14T0.06 1.31T0.17 0.83T0.02r Signaling
intermediates
1 BC022850.2 Transmembrane 9 superfamily protein
member 4
1 0.83T0.18 1.77T0.04* 1.19T0.03r 0.87T0.39 Signaling
intermediates
3 AF068868.1 TNFR-related death receptor-6 (DR6) 1 0.63T0.05r 0.94T0.05 0.98T0.02 0.81T0.07 Signaling
intermediates
1 NM_000801.2 FK506 binding protein 1A, 12 kDa (FKBP1A) 1 0.91T0.06 1.18T0.14 1.70T0.220 0.82T0.19 Signaling
intermediates
1 BC001522.2 GRIP1 associated protein 1 1 0.98T0.29 0.75T0.070 1.15T0.10 0.97T0.16 Signaling
intermediates
1 NM_0031035 SON DNA binding protein (SON) 1 0.52T0.02* 0.77T0.070 1.07T0.10 1.19T0.03r DNA-binding
proteins
1 BC006175.1 v-jun sarcoma virus 17 oncogene homolog 1 1.74T0.180 3.27T0.670 1.52T0.31 0.47T0.19 DNA-binding
proteins
1 NM_003675.2 PRP18 pre-mRNA processing
factor 18 homolog
1 0.71T0.15 0.60T0.06r 0.86T0.14 0.77T0.13 Posttranslation
modification
1 BC011754.2 Disulfide isomerase related protein 1 0.72T0.22 2.22T0.26r 1.11T0.22 0.85T0.42 Posttranslation
modification
1 BC012141.1 Nuclear RNA binding protein (p54nrb) 1 1.33T0.05r 0.72T0.15 0.72T0.00* 0.83T0.15 Posttranscription
modification
1 NM_003330.2 Thioredoxin reductase 1 (TXNRD1),
transcript variant 1
1 0.66T0.110 0.69T0.00* 0.86T0.10 1.12T0.05 Stress protection
1 AF003529.2 Glypican 3 (GPC3) 1 0.67T0.16 0.44T0.05* 0.56T0.130 0.98T0.13 Cell proliferation
1 AY422170.1 p53-inducible protein (PINH) 1 1.32T0.12 0.77T0.11 0.41T0.160 0.54T0.04* Cell proliferation
2 BC000379.2 Ubiquitin B 1 0.71T0.14 0.75T0.060 0.72T0.12 0.97T0.11 Proteolysis
1 AF221130 Chromatin remodeling factor WCRF180 1 0.84T0.060 0.61T0.07r 0.46T0.06r 0.72T0.13 Transcription
1 AY251272.1 CREBBP/EP300 inhibitor 2 (EID2) 1 0.95T0.14 0.77T0.070 0.74T0.080 0.95T0.10 Transcription
1 NM_006698.1 Bladder cancer associated protein (BLCAP) 1 0.66T0.07r 0.61T0.02r 0.84T0.040 0.82T0.03r Functionally
unclassified
1 BC032833.2 Ankyrin repeat domain 13 (NY-REN25) 1 0.69T0.17 1.01T0.11 1.28T0.070 1.07T0,31 Functionally
unclassified
1 BC011625.2 Zinc finger protein 503 1 1.64T0.04* 1.26T0.16 1.16T0.14 0.76T0.14 Functionally
unclassified
1 BC000687.2 Translocation associated membrane protein 1 1 0.42T0.34 0.63T0.06r 0.78T0.04r 0.81T0.060 Functionally
unclassified
For legend see Table 3.
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3.1. Effectiveness of stimulation of HepG2 cells by IL-6 and
IL-1/IL-6
In order to establish the experimental protocol, HepG2 cells
were treated with various concentrations of IL-1h or/and IL-6.
The dose and time-responses to these cytokines were obtained
for mRNAs coding for well-known acute phase proteins:
mitochondrial manganese superoxide dismutase (MnSOD)
[12] and two plasma proteins: haptoglobin (HPT) and a1-acid
glycoprotein (AGP) [13] (Fig. 1). On the ground of these results,
we selected concentrations of cytokines used in the differential
display analysis: 15 ng/ml of IL-1h and 25 ng/ml of IL-6.
As shown in Fig. 1, maximal abundance of the tested
mRNAs occurred either after 12 h of exposure to IL-6 alone
(HPT), or after 24 h exposure to IL-6 when the cells were
pretreated with IL-1h (MnSOD, AGP). The additive effects of
IL-1 and IL-6 are clearly visible for the two latter proteins
belonging to class I, whereas human HPT represents class II
being regulated by IL-6 alone [1].Table 3





3 AY495241.1 NADH dehydrogenase subunit 1 1
1 NM_004925.3 Aquaporin 3 (AQP3), 1
2 NM_001013.2 Ribosomal protein S9 (RPS9) 1
1 BC020515.1 Ribosomal protein S14 1
1 AK495323.1 Mit. tRNA-Ile 1
1 AY570526.1 Mit. tRNA-Tyr 1
1 AY570526.1 Mit. 16S ribosomal RNA 1
1 BC012141.1 Nuclear RNA binding protein (p54nrb) 1
1 AF239156 Deformylase-like protein mRNA 1
2 BC037428 RAVER1 1
2 BC006781.1 Myosin, light polypeptide 6 1
1 AF151978 Amino acid transporter B0+ (ATB0+) mRNA 1
1 BC012137.1 Syntaxin 5A 1
1 BC013017 CD63 antigen (melanoma 1 antigen) 1
2 AF068868.1 TNFR-related death receptor-6 (DR6) 1
1 AF035158 Serine/threonine protein phosphatase
catalytic subunit
1
1 NM_001238.1 Cyclin E1 (CCNE1) 1
1 AF003529.21 Glypican 3 (GPC3) 1
1 HSU75285 Survivin 1
1 BC007897.2 Proteasome 26S subunit, 1
1 BC010902.1 CGI-150 protein 1
2 AF277316.1 PWP1-interacting protein 8 percursor (PWP1) 1
1 NM_006698 Bladder cancer associated protein (BLCAP) 1
Fold change is a ratio of densitometric value of each analysed band correspondi
value of intensity of genomic DNA divided by the corresponding value of 1h
regulation of gene expression, and above 1 indicates up-regulation. Time of cells
7/4 indicates 7 h exposure to IL-1 and 4 h exposure to IL-6. The reported values
0P <0,05; rP <0,01; *P <0,001.3.2. Differential display analysis of IL-6-induced transcriptome
changes in HepG2 cells
After stimulation of HepG2 cells with IL-6 we found 100
differentiating PCR products from which 88 were success-
fully reamplified and cloned to pTZ57R vector as described
in Materials and methods. After searching the NCBI-BLAST
database we found homology sequence for 77 different
cDNAs. Many of the identified genes were represented by
more than one clone, thus from 77 identified genes 56
cDNA sequences corresponded to 38 different known genes
(Table 2). The remaining 18 clones contained new
transcripts: their sequences matched BAC and PAC clones
in NCBI database with the identity ranging from 85 to
100%. These sequences represent new full size cDNA
identified already by the complex transcriptome sequencing
analysis [14], or recognized as open reading frames in big
genomic clones; therefore, they have to be cloned and
characterized at 5V and 3V ends. The cloning procedure was
not successful for 12 clones, in which vector sequences
were inserted.time indicated
ange Classification
7/4 h 15/12 h 27/24 h C 24 h
0.47T0.01* 0.76T0.070 0.82T0.09 0.80T0.03r Metabolism
2.23T0.320 1.02T0.15 1.29T0.22 1.45T0.160 Metabolism
0.54T0.110 0.53T0.10r 0.41T0.08r 0.50T0.07r Protein synthesis
0.90T0.12 0.46T0.07r 0.62T0.100 1.14T0.06 Protein synthesis
0.45T0.11r 0.44T0.06* 0.62T0.02* 0.82T0.10 Protein synthesis
0.73T0.04r 0.53T0.04* 0.55T0.140 0.70T0.04r Protein synthesis
0.54T0.03* 0.72T0.05r 0.63T0.100 0.73T0.00* Protein synthesis
0.85T0.09 0.56T0.08r 0.49T0.06r 0.97T0.18 Posttranscription
modification
1.70T0.220 1.17T0.11 1.50T0.10r 1.05T0.13 Posttranslation
modification
0.82T0.08 0.79T0.040 0.71T0.080 0.69T0.110 RNA processing
0.91T0.06 0.87T0.040 0.77T0.060 0.78T0.05r Trafficking
0.90T0.01r 1.33T0.01* 1.25T0.18 1.43T0.01* Transport
1.27T0.01* 1.14T0.040 1.27T0.04r 1.06T0.05 Transport
0.39T0.13r 0.64T0.15 0.65T0.130 0.73T0.12 Signaling
intermediates
1.68T0.230 0.65T0.04* 0.65T0.17 0.93T0.08 Signaling
intermediates
1.47T0.130 0.83T0.07 0.87T0.05 1.03T0.05 Signaling
intermediates
0.55T0.09r 0.39T0.04* 0.92T0.14 1.14T0.01* Cell proliferation
0.86T0.10 0.70T0.080 0.62T0.01* 0.90T0.02r Cell proliferation
1.66T0.08r 1.18T0.07 1.03T0.02 1.24T0.14 Cell proliferation
0.77T0.03r 0.60T0.06r 0.60T0.07r 0.78T0.15 Proteolysis
0.79T0.01* 0.76T0.05r 0.65T0.03* 0.94T0.25 Functionally
unknown
1.42T0.07r 1.04T0.03 1.04T0.07 1.08T0.08 Functionally
unknown
0.74T0.05r 0.59T0.110 0.55T0.02* 0.91T0.00* Functionally
unknown
ng to individual gene at appropriate time of stimulation to the densitometric
control (see Fig. 3). Therefore, the ratio value below 1 indicates down-
collection for the analysis shows the exposure to the tested cytokines, e.g.,
represent the mean of three independent experiments. Statistical significance:
P. We˛grzyn et al. / Biochimica et Biophysica Acta 1762 (2006) 319–328 3253.3. Differential display analysis of transcriptome changes in
HepG2 cells stimulated with IL-1b followed by IL-6
In case of HepG2 cells prestimulated for 3 h with IL-1 and
then stimulated with IL-6, we excised 81 bands from the DD
gels, and 43 of them were successfully reamplified. All in all,
30 clones corresponded to known genes. Several genes, such as
NADH dehydrogenase subunit 1, ribosomal protein S9,
RAVER1, myosin light polypeptide 6, TNFR-related death
receptor 6 and PWP1-interacting protein 8 precursor were
represented by more than one clone, so finally 23 different
known genes were identified (Table 3). Ten clones had inserts
matching in NCBI data new cDNA clones or big genomic
clones with hypothetical cDNA sequences. Three of all
identified clones instead of cDNA insert contained vector
sequences. In this experiment the number of differentially
expressed bands seen on a polyacrylamide gel was consider-
ably smaller in comparison with experiments where cells were
treated with IL-6 only. Majority of these differentially
expressed bands were detected in a reproducible fashion in
DD analysis, but for some of them, we were not able to
optimize reaction conditions required for successful ream-
plification. Thus, almost half of the excised bands were not
reamplified, especially when the bands were recovered from
the dried gels.
4. Discussion
4.1. Response of HepG2 cells to IL-6 and IL-1
The results shown in Fig. 1 indicate that the employed
treatment of HepG2 cells with IL-6 alone or after prestimulation
with IL-1 leads to the development of typical acute phase
response. When comparing the presented data with previous
results [5] where HepG2 cells were stimulated with IL-1 alone,
we found that among transcripts identified as differentially
regulated by cytokines eight are controlled by both IL-1 alone
and IL-6 alone. These transcripts encode proteins representing
different functional groups: (a) engaged in metabolism (NADH
dehydrogenase subunit 1, glyceraldehyde-3-phosphate dehy-
drogenase); (b) synthesis and processing of transcripts (nuclear
RNA binding protein [p54nrb], aspartyl-tRNA synthetase,
CREBBP/EP300 inhibitor 2 [EID2]); (c) cellular structure
(kinesin 5 B, myosin-light polypeptide 6); and (d) signal
transmission (prosaposin). Moreover, NADH dehydrogenase
subunit 1 and myosin-light polypeptide 6 are the only two genes
responding to IL-1, IL-6 and the mixture of two cytokines.
Eighteen clones in the experiment when cells were
stimulated with IL-6, and ten clones after stimulation with
IL-1/IL-6, did not show homology with known and function-
ally classified genes deposited in GenBank entries. We are
currently engaged in the studies of these yet uncharacterized
transcripts since they appear to be involved in specific acute
phase response of HepG2 cells stimulated by both cytokines.
Using slot blot analysis, we have already confirmed that most
of them are indeed modulated by exposure of HepG2 cells to
IL-6 or IL-1/IL-6 (data not shown).When analysing all DD gels in experiments with IL-6 as the
only cytokine used for HepG2 cell stimulation, we observed
that the number of differentially expressed bands was much
higher in comparison with the experiments where two
cytokines (IL-1/IL-6) were used. This inhibitory effect of IL-
1 on the expression of some IL-6-inducible genes is a well
known phenomenon and can be explained by synthesis of
specific proteins (SOCS) or activation of MAP kinase pathway
[10,15], but these suggestions must be experimentally verified.
4.2. Possible biological functions of detected by us genes
coding cellular proteins regulated by IL-6 and IL-1
Besides two main groups of genes engaged in metabolism
and protein synthesis, there is a large group of genes coding for
proteins that play an important role as signalling molecules. In
the latter group significant changes in the level of expression
were observed for FK506 transcript: almost 2-fold up-
regulation was found after 24 h stimulation with IL-6. The
protein encoded by FK506 is a potent immunosuppressive
agent, highly effective in preventing organ transplant rejection
in humans. It was earlier reported that FK506 has a profound
anti-inflammatory effect [16]. Unfortunately, we did not detect
a cDNA fragment of this gene in the experiment when cells
were treated with IL-1/IL-6.
One of the genes modulated by IL-1/IL-6 codes for a
subunit of proteasome 26 S (Table 3). This protein complex is
an important player in NF-nB signaling pathway, responsible
for degradation of InB-inhibitor. The loss of InB permits
translocation of NF-nB to the nucleus [17] and subsequent
binding to the target genes. But Shen et al. [9] proposed a
model for a cross-talk between IL-1 and IL-6 transduction
pathways with an additional important role for proteasome 26
S. According to this model IL-1 inhibits IL-6-induced STAT-1
tyrosine phosphorylation by a proteasome-dependent mecha-
nism, followed by a down-regulation of IL-6-induced STAT
activation. Our slot blot experiment data show quite significant
decrease in the transcript level for a proteasome subunit.
Therefore, regarding the model of Shen [9] the decrease in the
transcript level may be associated not only with InB
degradation but also with inhibition of STAT1 activation. It
has been generally accepted now that the ubiquitin-proteasome
system is also involved in the transcriptional regulation (for
references, see Muratani and Tansey [18]).
Among all genes identified as differentially regulated under
stimulation by IL-6 or IL-1/IL-6 six were the same, detected in
both experiments. These include: NADH dehydrogenase
subunit 1, ribosomal protein S9, myosin-light polypeptide 6,
TNFR-related death receptor-6 (DR6), glypican 3 and bladder
cancer-associated protein. Only TNFR-related death receptor-6
protein product has been known so far to be engaged in NF-nB
signaling pathway. This protein belongs to the family of TNF
receptors and interacts with TRADD. Ectopic expression of
DR6 gene in mammalian cells induces apoptosis and activation
of both NF-nB and JNK [19]. It is interesting that the transcript
level of TNFR-related death receptor-6 is decreased to one half
after 4 h of IL-6 stimulation, and only after 24 h returns to
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exposure of cells to IL-1/IL-6: almost 2-fold up-regulation
occurs during the first 4 h following addition of cytokines and
later the transcript level decreases. A synergistic effect of IL-1/
IL-6 indicates that TNFR-related death receptor 6 belongs to
type 1 acute phase reactants [1].
We presume that glypican-3 (GPC3) is also directly engaged
in NF-nB signaling pathway, even if this property has not been
described so far. Literature data show that GPC3 plays a
negative role in cell proliferation, and blocking of endogenous
GPC3 expression with an antisense transcript promotes growth
of Hep3B cells [20].
Cytokine-modulated expression of several clones containing
inserts coding for NADH dehydrogenase subunit 1 and
ribosomal protein S9 (Table 2) is also understandable. As we
have shown in the earlier study, the exposure of HepG2 cells to
IL-1 leads to activation of the machinery responsible for cell
metabolism and protein synthesis [5].
The last gene belonging to the group of genes modulated by
IL-1/IL-6, bladder cancer associated protein, has unknown
functions and its involvement in the acute phase reaction
should be examined in detail.
The most frequently identified transcript (8 clones after IL-6
stimulation and 3 clones after IL-1/IL-6 stimulation), with quite
significant changes in its level, encodes NADH dehydrogenase
subunit 1. After times ranging from 12 to 24 h of HepG2 cells
stimulation with IL-6, we observed more than 3-fold up-
regulation of the transcript level (Table 2). It should be added
that all 4 subunits of NADH dehydrogenase are up-regulated
by the cytokines. In distinction to cells stimulated with IL-6
alone, pretreatment with IL-1 leads to a significant down-
regulation of the transcript level. The direct role of NADH
dehydrogenase subunit 1 in the inflammatory processes has not
been evaluated so far. Arai et al. [21] studied the importance of
reactive oxygen metabolites (ROMs) in up-regulation of
intercellular adhesion molecule 1 (ICAM-1) in endothelial
cells after stimulation with TNFa. They showed that NADH
dehydrogenase together with cytochrome bc1 and complex
NADPH oxidase are important enzymic sources of ROMs
involved in this signaling. Specific inhibitors of these enzymes
significantly decrease TNF-induced ICAM-1 expression. The
significance of ROMs in mediation of signal transduction from
various stimuli, including cytokines, endotoxins and PMAwas
postulated earlier but the source of ROMs was not clear
[22,23]. Our studies provide additional evidence that mito-
chondrial enzymes, including NADH dehydrogenase subunit 1,
may play an important role in the inflammatory processes.
Both cytokines modulate the expression of NADH dehydro-
genase subunit 1 but it looks that the joint action of IL-1/IL-6
inhibits its expression and in consequence ROMs production.
4.3. Technical problems encountered in the employed
differential display analysis
In both types of cell stimulation some of the excised bands
could not be amplified (12 in the IL-6 transcriptome profile
analysis and 38 in the IL-1/IL-6 experiment). As we hadnoticed previously one of the reasons explaining difficulties
with reamplification is low expression level of some genes
resulting in poor recovery of cDNA from the gel [5], especially
when the reaction was carried out after drying of the gel.
In two types of experiments (IL-6 alone or with IL-1), the
unstimulated cells served as control. RNA was isolated from
unstimulated cells after 1 h and 24 h of incubation. Comparing
the densitometric values of both controls, we observed some
differences in the transcript level of several genes, such as
NADH dehydrogenase subunit 1, ribosomal protein S9, v-jun
sarcoma virus 17, p53-inducible protein, zinc finger protein
503 (Tables 2 and 3). Many of identified genes belong to
‘‘housekeeping genes’’ and their protein products fulfil general
functions of cells. Therefore, it can be expected that modula-
tion of expression of these genes may not be controlled solely
by cytokines but is probably influenced by other factors. It is
possible that some tissue culture supplements, or confluency of
cultured cells, may also affect gene transcription or stability of
mRNAs. For this reason these housekeeping genes may not
always be reliable reference check-points, although, some of
them are still frequently used in the expression studies. Genes
encoding proteins responsible for cellular metabolism (such as
GAPDH) [24], for protein synthesis (such as elongation factor-
2) [25] or cytoskeletal proteins (such as beta-actin) [26] are
most often employed as control in Northern blot analysis,
semiquantitative PCR and real-time PCR. Using Northern blot
analysis, we observed significant changes in the transcript level
of genes mentioned above in HepG2 cells stimulated with
proinflammatory cytokines (data shown only for GAPDH;
Table 2). This is in agreement with earlier studies, showing that
activation of murine microvascular endothelial cells (MME)
with TNF-a and IFN-g resulted in a strong elevation of
GAPDH mRNA level [27].
For these reasons, we decided to use genomic DNA as a
standard during slot blot analysis. Since all PCR products (200
ng) on a slot blot membrane, representing different cDNA
fragments, are complementary to a defined region of genomic
DNA we used 50 ng of genomic DNA to establish the
background of the slot blot experiment, to control pipetting
errors and verify slot blot data. The value of intensity of each
band corresponding to individual gene and appropriate time of
stimulation was divided by the value of intensity of the spot
from genomic DNA. All statistical data were validated when 3
independent experiments were performed. This procedure is
depicted in detail in Fig. 3 for three genes modulated by IL-6
alone (A, B) and two genes modulated by IL-1/IL-6 (C, D).
4.4. Evaluation of differential display analysis as a method of
studying changes in the profile of transcriptome induced by
cytokines in HepG2 cells
The data presented in Tables 2 and 3 show that the identified
genes encode cellular proteins engaged in metabolism, protein
synthesis, trafficking, signal transduction, transcription, DNA
interaction, posttranscription/posttranslation modifications, cell
proliferation and proteolysis but none of these belong to typical
plasma acute phase proteins. There are several possible reasons
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were not found in our DD-PCR analysis. The differential
display is a simple screening method based on the PCR
reaction. The major feature of this method is the use of
arbitrary primers, which consist of different combinations of
nucleotides. These primers bind to random templates and even
at optimal PCR conditions are not sufficient to amplify all
cDNAs which are expressed in a cell at any given time. Thus,
this method enables to detect changes in the expression level of
only some of all expressed genes. Another explanation for the
lack of cDNA sequences encoding plasma acute phase proteins
is related to the mechanism of PCR reaction. If more than one
pair of primers is used in a PCR mix, for example as it is in
multiplex PCR, the smaller fragments are amplified more
efficiently than the larger fragments. Using specific primers, as
is done for multiplex PCR in deletion screening of the
dystrophin gene or profiling of STR (short tandem repeats)
loci, it is possible to optimize reaction conditions to obtain
several bands of different size, amplified with the same
efficiency [28,29]. Using arbitrary primers in DD-PCR we
were obtaining PCR fragments ranging from 600 to 2200 bp.
Primers annealing to random cDNA templates make impossi-
ble the choice of optimal conditions to generate all products
with equal efficiency. In many cases, we observed strong
signals from small fragments and weak signals from large
fragments (Fig. 2). Then, if PCR products are amplified with a
very low or a very high efficiency, the differences in the real
amplicon increase or decrease are not visible. Thus, part of
these PCR products are false-negatives because the real
changes in the expression level were not detectable. Therefore,
by analysing DD-PCR products on polyacrylamide gels we are
able to observe changes in the transcript level only for those
cDNA templates for which the reaction conditions appear to be
optimal.
One more reason for the lack on our list of genes encoding
plasma acute phase proteins may be the colony screening
procedure. In our experiments, PCR products with a visible
difference in the expression level under different time check
points were excised from gel, reamplified and cloned to a
plasmid vector. Then only 3 colonies from each plate were
subjected to sequencing. In several cases, we have observed
that the collected colonies do not contain the same insert. We
assume that the appearance of more than one cDNA in one
excised PCR product is quite a frequent phenomenon and
screening done only for three colonies out of all colonies
grown on the plate might decrease the real number of
differentially expressed genes.
The last, and probably the most important reason explaining
that in our study, we have not found a single plasma acute
phase protein gene is the ratio of intracellular proteins to
plasma proteins. It has been assumed that there are not more
that one hundred of acute phase proteins in plasma [13],
whereas a differentiated human cell expresses around 10,000
genes [30]. Since we detected cytokine-induced differences for
56 cDNA (38 known genes and 18 hypothetical cDNA) in IL-6
stimulation study and for 33 cDNA (23 known genes and 10
hypothetical cDNA) in IL-1/IL-6 stimulation study, we mighthave missed all mRNAs coding for plasma acute phase protein
genes.
4.5. Concluding remarks
The changes reported here in the transcriptome of HepG2
cells stimulated with IL-6 or IL-1/IL-6 appear to be more
complex than anticipated so far. After stimulation with 2
cytokines we identified 61 genes encoding cytoplasmatic and
nuclear proteins (Tables 2 and 3). Moreover, we found 28
templates representing hypothetical proteins or cDNA frag-
ments complementary to BAC/PAC clones, therefore, belong-
ing to genes not identified so far. For all known genes the
detailed analysis concerning changes in the transcript level was
carried out and is presented in Tables 2 and 3. Our experiments
suggest also that the inflammatory response of HepG2 cells is
a high energy-consuming process for the cells involved
because many of the identified genes participate in cellular
metabolism, such as mitochondrial genes of respiratory
complex I.
Up to now, there is no precise data as to how many genes
are expressed in HepG2 cells under proinflammatory cytokine
stimulation and all available methods used in the transcriptome
analysis offer certain advantages or disadvantages [3]. The
results presented here provide additional new information on
changes in gene expression of HepG2 cells stimulated with IL-
6 or IL-1/IL-6 for times ranging from 1 to 24 h. However, our
experiments indicate also that the differential display analysis–
being a valuable tool in discovering unknown cytokine-
responsive genes–cannot be used for evaluation of the
transcriptome profile because it may miss altogether products
of transcription of several genes for the reasons discussed in
detail above.
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